Peptide describes a substance
When an offer says peptide, it means a short linked string of protein building blocks; insulin is one example.
That word alone leaves a lot to ask. What substance is being offered? What is it meant to do for your particular problem? What would count as a reason to change the plan?
| On the page | What to ask for |
|---|---|
| Recovery program | A clear account of what is being assessed and what care is included. |
| Peptide therapy | The ingredient name, also called the generic name, rather than a label made for a program. |
| Personal plan | What in your history would change the recommendation. |
| Ongoing support | Who handles questions and when the plan is reviewed. |
Learn the words before comparing offers
- FDA
- The U.S. body for drug review is FDA, the Food and Drug Administration.
- Compounding
- Compounding can involve a pharmacist preparing a patient’s medicine rather than dispensing the drug company’s finished product.
FDA has not approved compounded medicines; that remains the position on September 26, 2026.
A prescription records a licensed prescriber’s order for a drug.
Ask which product would be supplied and which pharmacy would prepare or dispense it.
Keep a copy of the reply. A product name gives you something concrete to discuss at another visit or with the pharmacy.
Leave with a description you can repeat
Try this question: “Can you explain the plan without using the program name?”
The answer can cover the assessment, the treatment being considered, follow-up and the bill. Write down anything still missing.
Sources and when we checked them
The medicine terms: September 2026. Whether the product has FDA approval: September 26, 2026.